Skip to content

Released Nov 8, 2016, after the close

10-Q filed Nov 9, 2016, 40 days after period end · 0001162194-16-000248

Q3 2016 · 10-Q
Revenue$22.19M−22.5% vs Q3 2015−21.2% vs Q2 2016
Net Income-$19.79MN/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.68N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$18,483,000N/M
Operating Cash Flowderived-$13,262,000N/M
Free Cash Flowderived-$14,971,000N/M
Margins · derived
Operating margin-83.3%−56.0 pt vs Q3 2015
Net margin-89.2%−56.8 pt vs Q3 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2016Q3 2015Q3 2014Q3 2013
Revenue$22.19M$28.64M$29.64M$18.29M
Net Income-$19.79M-$9.27M-$13.79M-$4.29M
EPS Diluted-$0.68-$0.32-$0.49-$0.17

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR